These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9055732)

  • 1. Interferon beta in multiple sclerosis. Relapses deserve treatment.
    Cardy P
    BMJ; 1997 Feb; 314(7080):602. PubMed ID: 9055732
    [No Abstract]   [Full Text] [Related]  

  • 2. Interferon beta in multiple sclerosis. Reducing frequency and severity of relapses will be of great clinical benefit.
    Burnfield A
    BMJ; 1997 Feb; 314(7080):600. PubMed ID: 9055727
    [No Abstract]   [Full Text] [Related]  

  • 3. [Interferon-beta in the treatment of multiple sclerosis].
    Panelius M; Salonen R; Ruutiainen J
    Duodecim; 1995; 111(7):587-9. PubMed ID: 8681813
    [No Abstract]   [Full Text] [Related]  

  • 4. Interferon beta in multiple sclerosis. Interferon beta reduces overall relapse rate by one third.
    Napier JC
    BMJ; 1997 Feb; 314(7080):601. PubMed ID: 9055729
    [No Abstract]   [Full Text] [Related]  

  • 5. Beta-Interferon and multiple sclerosis: not a final solution to the problem.
    Compston A
    Br J Hosp Med; 1995 Jun 7-20; 53(11):547-9, 551, 553. PubMed ID: 7655750
    [No Abstract]   [Full Text] [Related]  

  • 6. [Interferon therapy of multiple sclerosis].
    Jensen D
    Tidsskr Nor Laegeforen; 1999 Sep; 119(21):3142-5. PubMed ID: 10522481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon beta produces only small benefits in multiple sclerosis.
    McKee L
    BMJ; 1998 May; 316(7142):1410. PubMed ID: 9616008
    [No Abstract]   [Full Text] [Related]  

  • 8. [Beta-interferon and multiple sclerosis].
    Clanet M
    Rev Neurol (Paris); 1993; 149(8-9):443-4. PubMed ID: 8009140
    [No Abstract]   [Full Text] [Related]  

  • 9. Interferon beta in the treatment of multiple sclerosis--closing remarks.
    Kappos L
    Mult Scler; 1995; 1 Suppl 1():S64-6. PubMed ID: 9345403
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of interferon beta in relapsing-remitting multiple sclerosis.
    Etheridge LJ; Beverley DW; Ferrie C; McManus E
    Arch Dis Child; 2004 Aug; 89(8):789-91. PubMed ID: 15269086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of relapsing-remitting multiple sclerosis with interferon beta type 1-b].
    Bencsik K; Rajda C; Klivényi P; Járdánházy T; Török M; Vécsei L
    Orv Hetil; 1999 Apr; 140(14):763-6. PubMed ID: 10224846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon beta in multiple sclerosis. Current policy is sensible.
    Price C
    BMJ; 1997 Feb; 314(7080):600-1. PubMed ID: 9055728
    [No Abstract]   [Full Text] [Related]  

  • 13. Interferon beta in multiple sclerosis. Some form of compromise must be accepted.
    Peltola J; Keranen T
    BMJ; 1997 Feb; 314(7080):602. PubMed ID: 9055733
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of multiple sclerosis--1. New drugs may be effective but there still are frequent relapses].
    Svenningsson A; Andersson M; Olsson T
    Lakartidningen; 1998 Dec; 95(49):5623-7, 5630. PubMed ID: 9863300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of disseminated sclerosis with beta-inferferon--why and why not?].
    Sørensen PS; De Neergaard L
    Ugeskr Laeger; 1999 May; 161(19):2790. PubMed ID: 10412314
    [No Abstract]   [Full Text] [Related]  

  • 16. Recombinant human interferon beta in the treatment of relapsing-remitting and secondary progressive multiple sclerosis.
    Sandberg-Wollheim M; Hommes OR; Hughes RA; Paty DW; Abdul-Ahad AK
    Mult Scler; 1995; 1 Suppl 1():S48-50. PubMed ID: 9345399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Interferon-beta 1B in the treatment of remittent-recurrent multiple sclerosis. Clinical experience of the Valencia group. Multiple sclerosis study group of the city of Valencia].
    Rev Neurol; 1997 Dec; 25(148):1876-9. PubMed ID: 9528021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple sclerosis.
    Boggild M; Ford H
    Clin Evid; 2004 Dec; (12):1843-60. PubMed ID: 15865753
    [No Abstract]   [Full Text] [Related]  

  • 19. How much can we learn from long-term extension trials in multiple sclerosis?
    Noseworthy JH
    Neurology; 2006 Sep; 67(6):930-1. PubMed ID: 17000954
    [No Abstract]   [Full Text] [Related]  

  • 20. [Interferon-beta in multiple sclerosis--who is going to be treated?].
    Aarli JA
    Tidsskr Nor Laegeforen; 1999 Sep; 119(21):3114. PubMed ID: 10522472
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.